Get the App
A

Annovis Bio (ANVS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Annovis Bio (ANVS)

Annovis Bio, Inc. operates as a biotechnology company. The Company develops drugs for alzheimer's and parkinson's disease, including the orphan indication dementia and alzheimer's in down syndrome. Annovis Bio serves customers in the State of Pennsyl... Read more

  • USD12.90
  • USD13.96
  • USD12.73
  • USD23.91
  • 4.30%
  • --
  • 14.00
  • 31.50k
  • 105M
  • 8.39
  • -4.00%

Stock News

3 Growth Stocks That Are Too Cheap to Ignore

45 minutes ago

3 Growth Stocks That Are Too Cheap to Ignore

Yahoo

South African Ruling Party's Ties With Russia Pose Risks

48 minutes ago

South African Ruling Party's Ties With Russia Pose Risks

Bloomberg

Outside the Box: Investments in a rut? Maybe it’s the Wall Street industrial complex.

1 hour ago

Outside the Box: Investments in a rut? Maybe it’s the Wall Street industrial complex.

MarketWatch

Tax Guy: My job is being eliminated and I will get a severance package. Is that considered income for IRS limits on Roth IRA contributions?

1 hour ago

Tax Guy: My job is being eliminated and I will get a severance package. Is that considered income for IRS limits on Roth IRA contributions?

MarketWatch

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium